{"id":10350,"date":"2024-07-26T16:02:09","date_gmt":"2024-07-26T13:02:09","guid":{"rendered":"https:\/\/ozgurkilickesmez.com\/?p=10350"},"modified":"2026-10-13T22:28:38","modified_gmt":"2026-10-13T19:28:38","slug":"radioembolization-treatment","status":"publish","type":"post","link":"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/","title":{"rendered":"Radioembolization (Y-90): Procedure, Benefits, Risks and Side Effects"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Radioembolization treatment is a targeted therapy for liver tumors. It involves injecting radioactive microspheres into the hepatic artery, delivering localized radiation to cancer cells while sparing surrounding healthy tissue.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This method is effective in primary liver cancers such as hepatocellular carcinoma and secondary metastases. By selectively irradiating tumors, radioembolization helps control growth and extend survival in patients not suitable for surgery.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Compared with systemic therapies, radioembolization provides higher local tumor control. It is particularly beneficial for patients with limited liver reserve or those who have failed conventional chemotherapy.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The procedure is performed under angiographic guidance. Careful vascular mapping ensures precise microsphere delivery, minimizes side effects, and optimizes therapeutic outcomes for long-term disease management.<\/span><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_89 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #ffffff;color:#ffffff\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #ffffff;color:#ffffff\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#What_Is_Radioembolization_Therapy\" >What Is Radioembolization Therapy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#How_Is_Radioembolization_Therapy_Performed\" >How Is Radioembolization Therapy Performed?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#For_Which_Cancer_Types_Is_Radioembolization_Therapy_Suitable\" >For Which Cancer Types Is Radioembolization Therapy Suitable?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#What_Are_the_Side_Effects_of_Radioembolization_Therapy\" >What Are the Side Effects of Radioembolization Therapy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#What_Is_the_Post%E2%80%91Procedure_Recovery_Process_for_Radioembolization_Therapy\" >What Is the Post\u2011Procedure Recovery Process for Radioembolization Therapy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#When_Can_Patients_Return_to_Daily_Life_After_Radioembolization_Therapy\" >When Can Patients Return to Daily Life After Radioembolization Therapy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#In_Which_Situations_Is_Radioembolization_Therapy_Not_Recommended\" >In Which Situations Is Radioembolization Therapy Not Recommended?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#What_Are_the_Long%E2%80%91Term_Outcomes_of_Radioembolization_Therapy\" >What Are the Long\u2011Term Outcomes of Radioembolization Therapy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#Do_Patients_Feel_Pain_During_Radioembolization_Therapy\" >Do Patients Feel Pain During Radioembolization Therapy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#Is_It_Possible_to_Combine_Radioembolization_Therapy_with_Other_Treatment_Modalities\" >Is It Possible to Combine Radioembolization Therapy with Other Treatment Modalities?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#Is_Radioembolization_Therapy_Suitable_for_Children\" >Is Radioembolization Therapy Suitable for Children?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#What_Are_the_Advantages_and_Disadvantages_of_Radioembolization_Therapy\" >What Are the Advantages and Disadvantages of Radioembolization Therapy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ozgurkilickesmez.com\/en\/radioembolization-treatment\/#What_Are_the_Latest_Developments_and_Research_in_Radioembolization_Therapy\" >What Are the Latest Developments and Research in Radioembolization Therapy?<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Radioembolization_Therapy\"><\/span>What Is Radioembolization Therapy?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><img decoding=\"async\" class=\"size-full wp-image-6531 aligncenter\" src=\"https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2024\/07\/TARE-KARACIGER-KANSERI.jpg\" alt=\"Before and after image of TARE liver cancer treatment\" width=\"1407\" height=\"987\" title=\"\" srcset=\"https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2024\/07\/TARE-KARACIGER-KANSERI.jpg 1407w, https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2024\/07\/TARE-KARACIGER-KANSERI-300x210.jpg 300w, https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2024\/07\/TARE-KARACIGER-KANSERI-1024x718.jpg 1024w\" sizes=\"(max-width: 1407px) 100vw, 1407px\" \/><\/p>\n<p>Radioembolization therapy is an effective way to combat tumors in the liver. It is used in the treatment of hepatocellular carcinoma and metastatic liver cancer. This method directly targets tumor areas. Yttrium-90 loaded microspheres are injected into the tumor-feeding arteries. The success of the treatment is based on its ability to deliver a high dose of radioactive material directly to the cancerous tissue.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Is_Radioembolization_Therapy_Performed\"><\/span>How Is Radioembolization Therapy Performed?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Radioembolization therapy encompasses a detailed process that is managed carefully. This treatment method is known as a minimally invasive procedure and is carried out step by step.<\/p>\n<p><strong>Pre\u2011Procedure Planning and Imaging:<\/strong><\/p>\n<ul>\n<li aria-level=\"1\">Patients are carefully selected and evaluated, with liver functions and tumor characteristics examined through various blood tests and imaging techniques.<\/li>\n<li aria-level=\"1\">The first step involves mapping the vessels via angiography to identify vessels that must be preserved.<\/li>\n<li aria-level=\"1\">A test performed with technetium\u201199m estimates the distribution of the microspheres and the lung shunt fraction.<\/li>\n<\/ul>\n<p><strong>Catheter Placement:<\/strong><\/p>\n<ul>\n<li aria-level=\"1\">A catheter is advanced from the femoral artery under fluoroscopic guidance into the hepatic artery. The correct placement of the catheter is confirmed using contrast dye.<\/li>\n<\/ul>\n<p><strong>Injection of Microspheres:<\/strong><\/p>\n<ul>\n<li aria-level=\"1\">Radioactive yttrium-90 microspheres are delivered via the catheter into the tumor\u2019s microvasculature. These microspheres emit beta particles to target cancer cells.<\/li>\n<li aria-level=\"1\">The infusion is performed slowly and in a controlled manner to ensure effective distribution of the microspheres and to minimize the risk to healthy tissue.<\/li>\n<\/ul>\n<p><strong>Post\u2011Procedure Care:<\/strong><\/p>\n<ul>\n<li aria-level=\"1\">The distribution of the microspheres is verified with SPECT or PET scans. These imaging techniques are critical in assessing the radiation dose and the treatment&#8217;s effectiveness.<\/li>\n<li aria-level=\"1\">Patients are closely monitored, with attention paid to pain, nausea, and other potential side effects.<\/li>\n<li aria-level=\"1\">Follow\u2011up imaging is used to evaluate the response to treatment and to plan any further interventions.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"For_Which_Cancer_Types_Is_Radioembolization_Therapy_Suitable\"><\/span>For Which Cancer Types Is Radioembolization Therapy Suitable?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Radioembolization therapy, performed using yttrium-90, is particularly effective in treating various types of liver cancers. The procedure is primarily applied to the following liver cancer types:<\/p>\n<ul>\n<li><strong>Hepatocellular Carcinoma (HCC):<\/strong> This method is frequently chosen for patients with advanced HCC who are not candidates for surgical intervention or who do not respond to other treatments. It slows disease progression and improves quality of life.<\/li>\n<li><strong>Intrahepatic Cholangiocarcinoma (iCCA):<\/strong> Used in cases where iCCA cannot be treated surgically and can be combined with chemotherapy for improved outcomes.<\/li>\n<li><strong>Colorectal Cancer Liver Metastases (CRC):<\/strong> In patients resistant to systemic chemotherapy, this treatment reduces the tumor burden in the liver and may render patients eligible for surgery.<\/li>\n<li><strong>Neuroendocrine Tumor Liver Metastases:<\/strong> Radioembolization plays an important role in reducing symptoms and shrinking tumors.<\/li>\n<li><strong>Breast Cancer Liver Metastases:<\/strong> In patients who do not respond to systemic treatments, reducing liver tumor burden can extend survival.<\/li>\n<li><strong>Other Gastrointestinal Malignancies:<\/strong> It is considered a palliative option for metastases from cancers such as pancreatic and gastric cancers.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_the_Side_Effects_of_Radioembolization_Therapy\"><\/span>What Are the Side Effects of Radioembolization Therapy?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The side effects of radioembolization therapy can range from mild symptoms to serious complications. One of the most common side effects is post\u2011radioembolization syndrome, where patients may experience fatigue, nausea, and abdominal pain. In most cases, these symptoms are transient and do not require special intervention. Nausea and vomiting are also common and are generally controlled with anti\u2011emetic medications.<\/p>\n<p>Common Side Effects:<\/p>\n<ul>\n<li><strong>Post\u2011Radioembolization Syndrome:<\/strong> Characterized by fatigue, nausea, vomiting, abdominal pain, and loss of appetite.<\/li>\n<li><strong>Nausea and Vomiting:<\/strong> Typically treated with ondansetron.<\/li>\n<\/ul>\n<p>Pain:<\/p>\n<ul>\n<li>Discomfort in the right upper quadrant and generalized abdominal discomfort.<\/li>\n<\/ul>\n<p>There are rarer, potentially serious side effects, including Radiation\u2011Induced Liver Disease (RILD), which manifests as impaired liver function and, in severe cases, may present with jaundice or ascites. Additionally, increases in liver function tests may be observed following treatment.<\/p>\n<p>Serious Complications:<\/p>\n<ul>\n<li>Radiation\u2011Induced Liver Disease (RILD): Impaired liver function.<\/li>\n<li>Liver Fibrosis and Portal Hypertension: Risks specific to treatments involving both lobes.<\/li>\n<li>Gastrointestinal Ulcers: May occur due to misplacement of the microspheres.<\/li>\n<li>Pulmonary Complications: Rarely, microspheres may migrate to the lungs.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_the_Post%E2%80%91Procedure_Recovery_Process_for_Radioembolization_Therapy\"><\/span>What Is the Post\u2011Procedure Recovery Process for Radioembolization Therapy?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The recovery process following radioembolization therapy involves several phases and may vary depending on the patient\u2019s condition. Immediately after the procedure, patients are typically observed in the hospital for a few hours to monitor for any complications, with close monitoring of vital signs.<\/p>\n<p><strong>Immediate Post\u2011Procedure Recovery:<\/strong><\/p>\n<ul>\n<li aria-level=\"1\">Patients may need to be observed for several hours or overnight.<\/li>\n<li aria-level=\"1\">Symptoms such as pain, nausea, and fatigue are common.<\/li>\n<li aria-level=\"1\">Pain relievers, anti\u2011emetics, and intravenous fluids are commonly administered.<\/li>\n<\/ul>\n<p><strong>Short\u2011Term Recovery:<\/strong><\/p>\n<ul>\n<li aria-level=\"1\">Fatigue, mild fever, and flu\u2011like symptoms typically resolve within one week.<\/li>\n<li aria-level=\"1\">Liver function tests and imaging are usually performed within the first month.<\/li>\n<li aria-level=\"1\">Patients are advised to avoid strenuous activities.<\/li>\n<\/ul>\n<p><strong>Long\u2011Term Recovery:<\/strong><\/p>\n<ul>\n<li aria-level=\"1\">Regular follow\u2011up visits are required.<\/li>\n<li aria-level=\"1\">Imaging studies at 1, 3, 6, and 12 months evaluate treatment response.<\/li>\n<li aria-level=\"1\">Continuous monitoring for rare long\u2011term complications is necessary.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"When_Can_Patients_Return_to_Daily_Life_After_Radioembolization_Therapy\"><\/span>When Can Patients Return to Daily Life After Radioembolization Therapy?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The recovery process after radioembolization therapy typically allows patients to return to daily activities within a few days. Most patients can resume normal activities shortly after a brief rest period. During recovery:<\/p>\n<ul>\n<li aria-level=\"1\">It is recommended that patients spend the first 2 to 6 hours in a recovery area.<\/li>\n<li aria-level=\"1\">The leg from which the catheter was inserted should remain immobile during this time.<\/li>\n<\/ul>\n<p>Before discharge, healthcare providers perform a series of checks, including:<\/p>\n<ul>\n<li aria-level=\"1\">Mobility<\/li>\n<li aria-level=\"1\">Ability to eat and drink<\/li>\n<li aria-level=\"1\">Independent performance of personal needs<\/li>\n<li aria-level=\"1\">Stable vital signs<\/li>\n<li aria-level=\"1\">Control of pain and nausea<\/li>\n<\/ul>\n<p>Once these assessments are favorable, patients are allowed to go home. Generally, patients adapt quickly to their normal routines after treatment.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"In_Which_Situations_Is_Radioembolization_Therapy_Not_Recommended\"><\/span>In Which Situations Is Radioembolization Therapy Not Recommended?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Radioembolization therapy is contraindicated in certain cases. Specific health conditions may prevent the safe application of this treatment. The patient\u2019s overall health and anatomical features determine whether the treatment can be safely performed.<\/p>\n<p>Significant hepatopulmonary shunting is a serious contraindication for radioembolization, as the risk of excessive radiation dose transfer to the lungs may lead to radiation pneumonitis, adversely affecting the patient&#8217;s quality of life. Severe liver dysfunction (Child\u2011Pugh score &gt; B7) is also a contraindication due to the high risk of post\u2011procedure hepatic decompensation.<\/p>\n<p>Other contraindications include:<\/p>\n<ul>\n<li><strong>Significant Hepatopulmonary Shunt:<\/strong> Situations where more than 30 Gy of radiation might pass to the lungs.<\/li>\n<li><strong>Impaired Liver Function:<\/strong> Cases with a Child\u2011Pugh score higher than B7.<\/li>\n<li><strong>Extrahepatic Disease:<\/strong> Patients with widespread extrahepatic disease.<\/li>\n<li><strong>Renal Failure:<\/strong> Patients with a creatinine clearance of less than 30 ml\/min.<\/li>\n<li><strong>Previous External Beam Radiation Therapy:<\/strong> Patients who have received extensive EBRT.<\/li>\n<li><strong>Pregnancy and Breastfeeding:<\/strong> Situations where radiation could harm the fetus or infant.<\/li>\n<li><strong>Life Expectancy Less Than 3 Months:<\/strong> Patients with very limited expected survival.<\/li>\n<li><strong>High Tumor Burden:<\/strong> When tumors occupy more than 50\u201370% of the liver.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_the_Long%E2%80%91Term_Outcomes_of_Radioembolization_Therapy\"><\/span>What Are the Long\u2011Term Outcomes of Radioembolization Therapy?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The long\u2011term outcomes of radioembolization therapy vary based on several factors. Using yttrium-90, this treatment has proven effective particularly in liver tumors. Post\u2011treatment tumor shrinkage can extend patient survival and improve quality of life. The treatment&#8217;s success varies by tumor type and stage, with some patients achieving high response rates.<\/p>\n<p>Long\u2011term outcomes include:<\/p>\n<ul>\n<li aria-level=\"1\">In hepatocellular carcinoma (HCC), the median overall survival ranges between 12 and 26 months.<\/li>\n<li aria-level=\"1\">Patients with neuroendocrine liver metastases (NELM) have a median overall survival of approximately 33 months.<\/li>\n<li aria-level=\"1\">1\u2011year survival rate of 75\u202f%<\/li>\n<li aria-level=\"1\">2\u2011year survival rate of 62\u202f%<\/li>\n<li aria-level=\"1\">3\u2011year survival rate of 46\u202f%<\/li>\n<li aria-level=\"1\">Similar improvements have been reported in colorectal cancer metastases and intrahepatic cholangiocarcinoma.<\/li>\n<\/ul>\n<p>While the treatment is generally well tolerated, some long\u2011term side effects may occur:<\/p>\n<ul>\n<li aria-level=\"1\">Chronic Radiation\u2011Induced Liver Disease (REILD)<\/li>\n<li aria-level=\"1\">Radiation gastritis<\/li>\n<li aria-level=\"1\">Gastrointestinal ulcers<\/li>\n<li aria-level=\"1\">Cholecystitis<\/li>\n<li aria-level=\"1\">Radiation pneumonitis<\/li>\n<\/ul>\n<p>These complications can be managed, and most patients benefit from the preservation of healthy liver tissue due to the minimally invasive nature of the treatment. Additionally, the tumor\u2011reducing ability may make some patients eligible for subsequent curative surgical options.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Do_Patients_Feel_Pain_During_Radioembolization_Therapy\"><\/span>Do Patients Feel Pain During Radioembolization Therapy?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pain is a common occurrence during radioembolization therapy. Patients often experience discomfort, particularly in the region where the catheter is inserted. As the catheter is advanced through the femoral artery to the hepatic artery, transient pain may occur. Local anesthesia is used to alleviate this pain. After the procedure, abdominal pain may develop, mainly due to the effects of radiation on the tissues.<\/p>\n<ul>\n<li aria-level=\"1\">The intensity and duration of the pain vary between patients.<\/li>\n<li aria-level=\"1\">Radiation-induced liver tissue reaction is the primary cause of abdominal pain.<\/li>\n<li aria-level=\"1\">Pain is usually managed with analgesics and tends to decrease within a few days.<\/li>\n<\/ul>\n<p>Some patients may also experience additional symptoms after the procedure:<\/p>\n<ul>\n<li aria-level=\"1\">Referred pain in the shoulder due to diaphragmatic irritation.<\/li>\n<li aria-level=\"1\">General fatigue, nausea, or vomiting.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Is_It_Possible_to_Combine_Radioembolization_Therapy_with_Other_Treatment_Modalities\"><\/span>Is It Possible to Combine Radioembolization Therapy with Other Treatment Modalities?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In modern oncology, radioembolization therapy is increasingly combined with other treatment methods to enhance its efficacy. Especially yttrium\u201190\u2013based radioembolization is integrated with various cancer treatment protocols:<\/p>\n<ul>\n<li><strong>In Combination with Immunotherapy:<\/strong> When used with immune checkpoint inhibitors, such as pembrolizumab, radioembolization can create synergy in the treatment of liver cancer by enhancing the immune response against tumor cells.<\/li>\n<li><strong>In Combination with Chemotherapy:<\/strong> When combined with systemic chemotherapy, radioembolization provides localized tumor control while chemotherapy addresses systemic disease. This combination can improve response rates in challenging cancers such as intrahepatic cholangiocarcinoma.<\/li>\n<li><strong>In Combination with Stereotactic Body Radiotherapy (SBRT):<\/strong> The combination targets both the parenchymal and vascular components of the tumor, significantly improving tumor control and overall treatment outcomes.<\/li>\n<li><strong>In Combination with Targeted Therapy:<\/strong> Integration with targeted agents, such as tyrosine kinase inhibitors, can enhance the effectiveness of both treatments, aiming for better local and systemic disease control.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Is_Radioembolization_Therapy_Suitable_for_Children\"><\/span>Is Radioembolization Therapy Suitable for Children?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The applicability of radioembolization therapy in children is still controversial due to limited scientific evidence. However, in recent years, treatments adjusted for children&#8217;s weight and BMI have been introduced.<\/p>\n<p>The decision-making process should be managed by a multidisciplinary team comprising pediatric oncologists, hepatologists, and interventional radiologists. One major concern in pediatric radioembolization is the potential effect of high\u2011dose beta radiation on growing tissues. Therefore, long\u2011term side effects and the management of radiation\u2011induced liver disease must be meticulously planned and monitored.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_the_Advantages_and_Disadvantages_of_Radioembolization_Therapy\"><\/span>What Are the Advantages and Disadvantages of Radioembolization Therapy?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Understanding the advantages and disadvantages of radioembolization therapy is essential to appreciate the scope and impact of this treatment. Radioembolization is a targeted approach to liver tumors that preserves healthy tissue while offering an effective solution.<\/p>\n<p>Advantages:<\/p>\n<ul>\n<li aria-level=\"1\">Targeted treatment minimizes damage to surrounding tissues and reduces systemic side effects.<\/li>\n<li aria-level=\"1\">As a minimally invasive procedure, it offers a shorter recovery time for patients.<\/li>\n<li aria-level=\"1\">It is effective even in tumors that cannot be surgically resected, thus broadening treatment options.<\/li>\n<li aria-level=\"1\">Provides a potentially curative option in early\u2011stage liver cancer.<\/li>\n<li aria-level=\"1\">In advanced stages, it alleviates symptoms and improves quality of life.<\/li>\n<\/ul>\n<p>Disadvantages:<\/p>\n<ul>\n<li aria-level=\"1\">Post\u2011radioembolization syndrome may affect a significant portion of patients.<\/li>\n<li aria-level=\"1\">Liver toxicity poses a risk, especially in patients with pre\u2011existing liver disease.<\/li>\n<li aria-level=\"1\">Misplacement of microspheres can lead to serious complications.<\/li>\n<li aria-level=\"1\">The treatment&#8217;s efficacy depends on tumor characteristics and overall liver health.<\/li>\n<li aria-level=\"1\">Cost and availability may limit access for some patients.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_the_Latest_Developments_and_Research_in_Radioembolization_Therapy\"><\/span>What Are the Latest Developments and Research in Radioembolization Therapy?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Recent advancements in radioembolization therapy are drawing attention, particularly beyond the use of yttrium\u201190. Innovations include new imaging technologies and dosimetry methods that allow for more precise tumor localization and dosing adjustments.<\/p>\n<p>The use of holmium\u2011166 as an alternative to Y\u201190, with its unique physical properties, enables improved tumor mapping. Additionally, combining Y\u201190 radioembolization with immunotherapy agents such as pembrolizumab has shown promising results in clinical trials, enhancing the immune system&#8217;s ability to target tumors.<\/p>\n<p>Improvements in radioembolization techniques, notably radiation segmentectomy, offer potential curative results for patients with early\u2011stage HCC while preserving non\u2011tumorous liver tissue.<\/p>\n<p>Recent clinical trials have demonstrated improved overall survival with Y\u201190 radioembolization. The LEGACY study, for instance, reported high tumor control rates in unresectable HCC. Furthermore, safety improvements such as prophylactic antibiotic use to prevent liver abscess formation have become integral to the treatment process.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Radioembolization treatment is a targeted therapy for liver tumors. It involves injecting radioactive microspheres into the hepatic artery, delivering localized radiation to cancer cells while sparing surrounding healthy tissue. This method is effective in primary liver cancers such as hepatocellular carcinoma and secondary metastases. By selectively irradiating tumors, radioembolization helps control growth and extend survival [&#8230;]\n","protected":false},"author":2,"featured_media":10355,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[320],"tags":[],"class_list":["post-10350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-treatments"],"_links":{"self":[{"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/posts\/10350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/comments?post=10350"}],"version-history":[{"count":3,"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/posts\/10350\/revisions"}],"predecessor-version":[{"id":16710,"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/posts\/10350\/revisions\/16710"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/media\/10355"}],"wp:attachment":[{"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/media?parent=10350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/categories?post=10350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/en\/wp-json\/wp\/v2\/tags?post=10350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}